Objective: To characterize circulating carotenoid and tocopherol levels in Nepali women during pregnancy and post-partum and to determine the effects of b-carotene and vitamin A supplementation on their concentration in serum. Design: Randomized community supplementation trial. Setting: The study was carried out from 1994 to 1997 in the Southern, rural plains District of Sarlahi, Nepal. Subjects: A total of 1431 married women had an ascertained pregnancy, of whom 1186 (83%) provided an analyzable serum sample during pregnancy; 1098 (77%) provided an analyzable 3 ± 4 months post-partum serum sample. Interventions: Women received a weekly dose of vitamin A (7000 mg RE), b-carotene (42 mg) or placebo before, during and after pregnancy. Serum was analyzed for retinol, a-tocopherol, g-tocopherol, b-carotene, a-carotene, lycopene, lutein zeaxanthin, and b-cryptoxanthin concentrations during mid-pregnancy and at $3 months post-partum. Results: Compared to placebo, serum retinol, b-carotene, g-tocopherol, b-cryptoxanthin and lutein zeaxanthin concentrations were higher among b-carotene recipients during pregnancy and, except for b-cryptoxanthin, at postpartum. In the vitamin A group, serum retinol and b-cryptoxanthin were higher during pregnancy, and retinol and g-tocopherol higher at postpartum. Lutein zeaxanthin was the dominant carotenoid, regardless of treatment group, followed by serum b-carotene. Serum lycopene level was lowest, and very low compared to the US population. Serum retinol was higher, and carotenoid and a-tocopherol lower, at postpartum than during pregnancy in all groups. Conclusions: Pregnant and lactating Nepali women have lower serum carotenoid and tocopherol levels than wellnourished populations. b-carotene supplementation appeared to increase levels of tocopherol and other carotenoids in this population.
Introduction
In recent years, the consumption of foods high in carotenoid or their puri®ed forms, especially b-carotene, have been of interest in industrialized countries due to possible preventative effects on cancer and cardiovascular diseases (Jha et al, 1995; Van Poppel & Goldbohm, 1995; Malone, 1991; Ziegler, 1989 ). More than 600 chemically different carotenoids have been characterized (Olson, 1990) . The six major carotenoids found in human blood are b-carotene, a-carotene, b-crypotoxanthin, lycopene, lutein and zeaxanthin, the latter two being mostly reported combined. In well-nourished Western populations the level of serum lycopene has been reported to be higher than other carotenoids (Ascherio et al, 1992; Forman et al, 1996; Nierenberg et al, 1997; Can®eld et al, 1997 Can®eld et al, ,1998 , possibly due to higher consumption of tomato products, which are high in lycopene. In contrast, circulating levels of lutein have been found to be higher and lycopene lower in women in one rural African population (Malawi); (Lan et al, 1999) and in Japan among males (Kitamura et al, 1997) compared to healthy American adults. This could be due to higher consumption of foods high in lutein, such as dark green leafy vegetables in these populations. Some carotenoids such as b-carotene, a-carotene, and b-crypotoxanthin have provitamin A activity which, when present in the diet, helps protect undernourished populations from vitamin A de®ciency.
In well-nourished groups, high-dose b-carotene supplementation increased circulating levels of b-carotene, a-carotene and lycopene and reduced lutein concentration (Nierenberg et al, 1997; Wahlqvist et al, 1994; Albanes et al, 1992; Micozzi et al, 1992; Kostic et al, 1995) . Large doses of b-carotene have been reported to lower vitamin E concentrations in animals and humans (Xu et al, 1992; Mobarhan et al, 1994) . Others have found both serum retinol and a-tocopherol levels not to change after long-term b-carotene supplementation (Nierenberg et al, 1997; Albanes et al, 1992; Micozzi et al, 1992; Willett et al, 1983) . There are many more reports of carotenoid interactions, which van den Berg (1999) has reviewed in detail. In undernourished populations, the majority of studies reporting nutritional effects of b-carotene intake, either in dietary or puri®ed form, have focused on changes in serum retinol concentration. Few data exist characterizing the serum carotenoid and tocopherol distributions in undernourished populations (Lan et al, 1999) and little information is available on the effects of b-carotene or vitamin A supplementation on tocopherol or other carotenoid concentrations in such groups. If tissue concentrations of these compounds affect health, then it is of interest to investigate the impact of carotenoid supplementation on circulating levels of these analytes. To our knowledge no studies have reported the effects of b-carotene supplementation on serum carotenoid and tocopherol pro®les in malnourished populations of pregnant and lactating women.
The present study was carried out: (1) to characterize the circulating levels of major carotenoid and tocopherol in a population of rural, Nepalese women during and shortly after pregnancy; and (2) to determine the impact of long-term, low-dose weekly b-carotene and vitamin A supplementation on circulating maternal levels of retinol, tocopherol and carotenoid. The study formed part of a large randomized, double-masked, placebo-controlled community trial in Nepal that observed routine maternal vitamin A or b-carotene supplementation to reduce mortality related to pregnancy by more than 40% (West et al, 1999) .
Methods and materials

Field procedures
The study was carried out from 1994 to 1997 in the southern, rural plains district of Sarlahi, Nepal. Details of the intervention trial and effects of supplementation on mortality of women related to pregnancy (West et al, 1999; Christian et al, 2000) , fetal loss and infant mortality have been reported . The protocol was approved by the Nepal Health Research Council in Kathmandu, Nepal and the Joint Committee on Clinical Investigation at the Johns Hopkins School of Medicine, Baltimore, MD.
Brie¯y, married women of reproductive age were randomized by ward to receive weekly a capsule containing 7000 mg retinol equivalents (RE) as preformed retinylpalmitate (providing 1000 mg REad, an equivalent of $1 RDA), 42 mg of b-carotene ( $ 7000 mg RE at a 6:1 conversion ratio) or a placebo. All capsules contained a negligible amount of DL a-tocopherol (5 mg), added as an antioxidant preservative. Women were continuously supplemented before, during, and after their pregnancies for a period of $ 3 1 2 y. The present study was conducted in a subset of 27 contiguous wards (nine randomized to each type of supplement) of a total of 270 wards that participated in the larger trial. Women were visited at home and dosed weekly, at which time pregnancy status was also monitored by history. Following informed consent, women reporting to be pregnant were enrolled into a clinic-based sub-study at a median gestational age of 4 months. Subjects were transported to a clinic where blood was drawn by venipuncture. Approximately 3 months after delivery, mothers returned to the clinic for a second phlebotomy. A 7 day food frequency questionnaire was administrated to most women $1 week before blood was drawn during pregnancy and postpartum.
Non-fasting blood was collected into vacutainers that were wrapped in aluminum foil and kept at room temperature for approximately 1 ± 2 h. Tubes were then centrifuged (1500 g) for 20 min. Serum was separated and kept in liquid nitrogen both in the ®eld and during transport to Johns Hopkins University in Baltimore where samples were stored at 780 C until time of analysis.
Chemicals and reagents
All reagents were HPLC grade, purchased from JT Baker (Phillipsburg, NJ). Trans-retinol, lycopene, a-and b-carotene, and a-and g-tocopherol standards were obtained from Sigma Chemical Company (St Louis, MO). F. Khachik (University of Maryland, College Park, MD) kindly provided b-cryptoxanthin, lutein and zeaxanthin standards. Ethyl b-apo-8 H -carotenal was purchased from Fluka Company, and used as internal standard.
Laboratory analysis
Serum samples were analyzed for total cholesterol and triglyceride enzymatically using kits purchased from Sigma Chemical Co. Serum samples were analyzed for simultaneous determination of retinol, a-and g-tocopherol, lutein zeaxanthin, lycopene, b-crypotoxanthin and aand b-carotene by a reverse-phase high-performance liquid chromatography (HPLC) using a modi®ed method of Nomura et al (1997) . Approximately 200 ± 400 ml of serum was deproteinized with an equal volume of ethanol containing an internal standard (Ethyl b-apo-8 H -carotenal) to which 800 ml of hexane was added. The mixture was vortexed and centrifuged. The hexane layer (top part) was removed to a clean test tube. The procedure was repeated on the aqueous solution. The hexane layers were pooled together and dried under nitrogen. The dried residue was dissolved in the mobile phase: dichloromethane (4:1) and then placed in the ultrasonic bath for 1 min, vortexed and centrifuged for 3 min to remove the impurities. A 20 ± 40 ml of sample was injected into a Beckman, System Gold HPLC (Beckman, Columbia, MD) with a Scanning Detector (Module 167) attached to an automated auto-sampler (717Plus AS, Waters Associates, Milford, MA). The column (Spherisorb, ODS2, 3 m, 150 Â 4.6 mm, Alltech Associate) with a similar packing guard column (40 Â 4.6 mm) was eluted isocratically with acetonitrile:-dioxane:methanol (0.15 M ammonium acetate added); (83:13:4) and 1% of triethylamine. The detector was set in channel A at wavelength 325 nm to detect retinol, then was changed to 295 nm for tocopherol and 450 nm for detection of lutein zeaxanthin, lycopene and a-and b-carotene. The channel B was also set at 450 nm for detection of b-cryptoxanthin. The precision and accuracy of the method was checked by serum standard reference material (SRM 968B) which was purchased from the National Institute of Standard and Technology (NIST, Gaithersburg, MD) and multiple serum samples from a serum pool were analyzed daily. All analyses were conducted in the Center for Human Nutrition laboratory at Johns Hopkins, which participates in the NIST round robin sample analysis program that monitors the accuracy of the methods used for this study.
Statistical analysis
Only the ®rst enrolled pregnancy of each recruited woman was eligible for this study. Pre-intervention baseline blood samples were not collected. We consider pregnancy and postpartum serum analyte distributions among placebo recipients to represent the unintervened state against which effects of supplementation are compared. Differences in analyte concentrations across the three supplement groups were ®rst tested by analysis of variance, followed by a t-test to compare individual groups. Multiple linear regression analysis was used to estimate mean differences in analyte concentration between groups of women receiving either vitamin A or b-carotene vs placebo, adjusted for differences in maternal age, mid-upper arm circumference (MUAC), reported consumption of selected high-carotenoid foods (mango, papaya, orange, tomato and green leafy vegetable), smoking and drinking of alcohol during the week prior to blood draw, season, serum total lipid (cholesterol trigylceride) concentration, socio-economic status (owning a radio, and reading or writing) and duration of supplementation. Standard errors obtained for b-coef®-cients were used to test values for statistical signi®cance against a null of zero. The Statistical Analysis System (version 6.12, SAS Institute Inc, Cary, NC) software package was used for data analysis.
Results
A total of 1431 women had an ascertained pregnancy in the substudy area (427 placebo, 530 b-carotene, 474 vitamin A), of whom 1186 (83%) (344 placebo, 450 b-carotene, 392 vitamin A) provided an analyzable serum specimen during pregnancy and 1098 (77%) (316 placebo, 405 bcarotene, 377 vitamin A) provided an analyzable 3 ± 4 month post-partum serum specimen.
Age, weight, height, BMI, MUAC and parity were comparable in all three groups of women at the time of pregnancy and postpartum assessments (Table 1) . Anthropometric indicators re¯ect a stunted, low-weight and wasted population of adult women compared to populations in developed countries (Frisancho, 1981 ; US Department of Health, Education and Welfare, 1979). Higher percentages of women in the b-carotene group smoked cigarettes, drank alcoholic beverages, owned radios and were literate than either the vitamin A or placebo groups (Table 1) . Women had been supplemented, on average, for 12 months prior to pregnancy assessment. Women in the b-carotene group took a smaller percentage of their eligible supplements throughout the study and in the 3 months prior to blood being drawn, compared to women in the vitamin A and placebo groups. Approximately 50% of women during pregnancy and 100% in the postpartum period were breast-feeding (Table 1) . Fewer placebo mothers reported consuming ripe papaya and tomato than women in other groups (Table 2) .
Compared to placebo recipients, serum retinol during pregnancy was higher among vitamin A ( 23%) and, to a lesser extent b-carotene supplemented ( 10%) women (Table 3) . Pregnant women given b-carotene supplements had signi®cantly higher serum levels of b-carotene ( 26%), b-cryptoxanthin ( 29%), lutein zeaxanthin ( 10%), and lycopene ( 31%) compared to women in the placebo group. Serum a-tocopherol was higher in the bcarotene group compared to either the placebo or vitamin A groups. Vitamin A supplemented women had circulating carotenoid and tocopherol levels during pregnancy that were comparable to placebo recipients, with the exception of b-cryptoxanthin. The total carotenoid level was higher in the b-carotene than other two groups. Total cholesterol (mmolal; placebo 4.1 AE 1.3, vitamin A 3.9 AE 1.1, bcarotene 4.0 AE 1.2) and triglyceride (mmolal; placebo 1.42 AE 0.64, vitamin A 1.41 AE 0.64, b-carotene 1.40 AE 0.62) concentrations during pregnancy were not different across treatment groups.
In the post-partum period, women given vitamin A had a mean serum retinol concentration that was 35% and 20% signi®cantly above that in placebo and b-carotene recipients, respectively (Table 4) . b-Carotene supplement use was associated with higher post-partum levels of a-tocopherol ( 8%), g-tocopherol ( 13%), a-carotene ( 31%, P 0.089), bcarotene ( 40%), b-cryptoxanthin ( 24%), lutein zeaxanthin ( 16%), lycopene ( 92%), and total carotenoid (25%) compared to placebo use. b-Carotene supplemented women also tended to have marginally higher carotenoid and tocopherol concentrations than women taking vitamin A. As during pregnancy, total cholesterol (mmolal; placebo 3.6AE 1.1, vitamin A 3.55AE 1.03, bcarotene 3.55AE 1.07) and triglyceride (placebo 0.92AE 0.47, vitamin A 0.94AE 0.51, b-carotene 0.92AE 0.51) concentrations were nearly identical across treatment groups during lactation. Except for retinol and g-tocopherol, serum concentrations of all measured analytes were lower during post-partum than pregnancy periods.
Vitamin A and b-carotene supplement-placebo differences in analyte concentrations were adjusted for imbalance, potentially confounding maternal demographic, nutritional and socioeconomic factors (Table 5) . Serum retinol increments during pregnancy and post-partum states remained signi®cantly higher than placebo. Although patterns of differences remained, a-tocopherol and bcryptoxanthin increments in the b-carotene group were no longer statistically signi®cantly higher among postpartum women. Differences in serum lycopene concentration were also not signi®cantly different after adjustment. All other adjusted supplement ± placebo differences remained signi®cant. Interval extends from week a woman was enrolled into the trial until the week blood was drawn. d Ability to read or write a letter.
A,B,C
Means with different superscripts indicate signi®cant differences between treatments at P`0.05.
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Discussion
Long-term oral vitamin A and b-carotene supplementation of Nepalese women increased gestational and postpartum circulating levels of retinol, compared to placebo controls, in an expected order, direction and magnitude for a chronically malnourished, vitamin A-de®cient population. In such populations, supplementation with preformed vitamin A may be expected to markedly raise the serum retinol concentration, whereas b-carotene supplementation will also increase serum retinol, but more slowly and to a lower concentration (Rice et al, 1999) . We also observed absolute mean serum concentration increases in b-carotene, a-and g-tocopherol, lycopene, lutein zeaxanthin and b-cryptoxanthin among b-carotene recipients compared to other groups. After adjusting for multiple, potential confounders, b-carotene recipient serum levels remained signi®cantly higher than those in the placebo group with respect to serum retinol, b-carotene, g-tocopherol, b-cryptoxanthin and lutein zeaxanthin during pregnancy and, except for b-cryptoxanthin, post- partum periods. Among vitamin A recipients, analytes for which serum increments over placebo remained statistically signi®cant after adjustment were retinol and b-cryptoxanthin during pregnancy and retinol and g-tocopherol during post-partum. We conclude that the gestational and postpartum serum concentrations of several carotenoid and tocopherol, some of which have known antioxidant function, were increased in chronically malnourished Nepalese women who were supplemented with 42 mg of b-carotene on a weekly basis. Arithmetically, the supplement was equivalent to 6 mgaday, an amount representing a normal dietary intake, although inef®ciencies that may have existed in absorbing and utilizing a single, weekly large bolus of b-carotene were unknown. These ®ndings contrast with mixed results from trials in well-nourished populations. A recent study by Mayne et al (1998) reported that up to 60 months of b-carotene supplementation (50 mgaday) did not affect serum retinol, a-tocopherol, lycopene and lutein zeaxanthin concentrations. The serum a-carotene level was increased 2-fold after supplementation, but the authors suggested that this might have been due to contamination of capsules with a-carotene (Mayne et al, 1998) . Wahlqvist et al (1994) observed an increase in serum b-carotene, lycopene, and a-carotene following b-carotene supplementation (20 mgaday) for 2 y. Albanes et al (1992) also reported that, following 2 months of b-carotene (20 mgaday) supplementation, there was a marked increase in serum bcarotene, a-carotene and b-cryptoxanthin but a signi®cantly reduced lutein concentration compared to a non-supplemented group. Similarly, decreases in lutein concentration were reported by Micozzi et al (1992) following b-carotene supplementation. Nierenberg et al (1997) observed signi®-cant increases in circulating levels of serum b-carotene but no change in retinol, a-tocopherol or other carotenoid concentrations following supplementation with 25 mgaday of b-carotene for 4 y compared to placebo. Willett et al (1983) observed no changes in vitamin E level in wellnourished adults after b-carotene supplementation. Xu et al (1992) , however, observed a signi®cant decrease in plasma tocopherol after 6 months of b-carotene supplementation (15 ± 60 mgaday). Similar results were reported from their animal data (Xu et al, 1992) and by others (Mobarhan et al, 1994) . In adequately nourished individuals given large doses of lipid soluble molecules, such as carotenoid, it has been suggested that there may be competition at the micellar solubilization stage within the intestine that may affect ef®ciency of absorption (Xu et, 1992; Willett et al, 1983) . Further, Kostic et al (1995) have also reported that there might be a competitive effect on carotenoid as well. They observed that the mean area under the curve for plasma lutein was reduced after administration of b-carotene and lutein supplements together. In contrast, competitive or negative effects of b-carotene supplementation on the status of other carotenoid and tocopherol were not evident from distribution in serum in rural Nepalese women.
Lutein zeaxanthin was the primary circulating carotenoid both during pregnancy and post-partum periods, accounting for 63 ± 69% of all those measured. The circulating lutein zeaxanthin level in this Nepali population was similar (Ribaya-Mercado et al, 1995; Rock et al, 1995) or higher (Ascherio et al, 1992; Forman et al, 1996; Can®eld et al, 1997 Can®eld et al, ,1998 Mayne et al, 1998) than reported among American adults. This comparability, between a markedly malnourished population in Nepal and wellnourished groups in the United States, is unexplainable. It could be due to an intake of leafy and green vegetables that is comparable to or higher than in the United States, but dietary data revealed only $ 60% of Nepalese women in our study consumed green leaves weekly (Table 2) , and only $ 16% more than one time per week (West et al, 1999) . Other carotenoid-rich foods tended to be consumed even less frequently. However, the level of lutein zeaxanthin in our women was lower than seen among pregnant women in Malawi (Lan et al, 1999) , suggesting even higher intakes or other unknown factors that in¯uence circulating levels of carotenoids in such rural populations.
Serum b-carotene was the second highest circulating carotenoid, which accounted for 20 ± 28% of all measured carotenoid during pregnancy and post-partum periods. The level of circulating b-carotene in our population was much lower than distributions reported in the well-nourished lactating (Can®eld et al, 1997 (Can®eld et al, ,1998 or non-lactating women (Forman et al, 1996; Rock et al, 1995) . This may Retinol, tocopherol and carotenoid in Nepali women S Yamini et al not be surprising among controls, given the low intakes of vegetables, fruit and dietary fat (data not shown) that might be expected to enhance carotenoid absorption (Takyi, 1999) . However, serum concentration of b-carotene was exceedingly low even among women routinely supplemented with b-carotene, perhaps re¯ecting combined effects of inef®cient absorption of a single, large weekly supplement, ef®cient bioconversion of absorbed b-carotene to retinol in vitamin A-de®cient individuals (van Vliet et al, 1996) or rapid utilization of absorbed and intact b-carotene for possible antioxidant (Allard et al, 1994) or other metabolic (Moriguchi et al, 1996; Prabhala et al, 1991) functions. Serum lycopene was very low in our women, as has been observed in Malawi (Lan et al, 1999) . During pregnancy serum lycopene only accounted for $ 3% of all circulating carotenoid, and comprised less than 0.5% during post-partum. In contrast, lycopene is one of the predominant blood carotenoids in premenopausal women (Forman et al, 1996; Can®eld et al, 1997 Can®eld et al, ,1998 Rock et al, 1995) and other healthy groups (Ascherio et al, 1992; Nierenberg et al, 1997) living in the United States. The b-cryptoxanthin level in our pregnant women was similar to those reported in Malawian pregnant women (Lan et al, 1999) , but lower than seen in American populations (Forman et al, 1996; Can®eld et al, 1997 Can®eld et al, ,1998 Rock et al, 1995) . Circulating a-tocopherol levels were 45 ± 75% lower in our population than in well-nourished lactating women or other healthy American men or women (Ascherio et al, 1992; Mayne et al, 1998; Ribaya-Mercado et al, 1995) .
Although serum carotenoid and tocopherol levels remained generally below concentrations observed in well-nourished populations, regular, weekly provision of a dietary b-carotene supplement to women of reproductive age resulted in signi®cant elevations in serum retinol, gtocopherol, b-cryptoxanthin and lutein zeaxanthin. Vitamin A supplementation had a lesser effect, but neither intervention provided evidence of decreasing other carotenoid or tocopherol concentrations, as has been observed in well-nourished populations.
